HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Brought to you by

Medtronic acquires Ardian for $800mm in cash, plus earn-outs

Executive Summary

Medtronic Inc. has agreed to buy the remaining 89% of closely held Ardian Inc. (catheter-based treatment of drug-resistant hypertension) that it does not already own for $800mm in cash. Shareholders may also receive earn-outs equal to the annual revenue growth through Medtronic's FYE 2015 (estimated at $500mm).
Deal Industry
  • Medical Devices
  • Medical Devices
    • Implantable Devices
    • Radiofrequency Devices
    • Surgical Equipment & Devices
Deal Status
  • Final
Deal Type
  • Acquisition
    • Includes Earnout
    • Partial Acquisition
    • Payment Includes Cash

Related Companies

UsernamePublicRestriction

Register